Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Yucheng Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3856-0807; OpenAlex author ID A5027149423. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Factors associated with adjuvant chemotherapy tolerance in pancreatic adenocarcinoma following pancreaticoduodenectomy: insights from minimally invasive surger… Last author DOI 10.1007/s00423-026-04241-w↗
  2. PLA2G16 expression predicts prognosis and gemcitabine sensitivity in patients with pancreatic cancer. Last author DOI 10.7717/peerj.19517↗
  3. Selective extended dissection for pancreaticoduodenectomy is associated with better survival in pancreatic cancer patients: retrospective cohort study. Co-author DOI 10.1097/js9.0000000000000437↗
  4. Factors predicting recurrence after left‑sided pancreatectomy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12957-023-03080-z↗
  5. Clinical outcome comparison of laparoscopic radical antegrade modular pancreatosplenectomy vs. laparoscopic distal pancreatosplenectomy for left-sided pancreat… Co-author DOI 10.3389/fsurg.2022.981591↗
  6. Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic outcomes and long-term survival. First author DOI 10.1007/s00464-019-06968-8↗
  7. Comparison of overall survival and perioperative outcomes of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal adenoc… Last author DOI 10.1186/s12885-019-6001-x↗
  8. Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis. Co-author DOI 10.1186/s40880-019-0410-8↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chao Lu · 3 shared papers, 2019–2026 · strength 0.59
  2. Weiwei Jin · 4 shared papers, 2019–2023 · strength 0.52
  3. Yiping Mou · 4 shared papers, 2019–2023 · strength 0.52
  4. Peng Xu · 2 shared papers, 2022–2023 · strength 0.32
  5. Yuanyu Wang · 2 shared papers, 2020–2023 · strength 0.28
  6. Xinbing Sui · 1 shared paper, 2025 · strength 0.27
  7. Xiaoyu Sun · 1 shared paper, 2025 · strength 0.27
  8. Nan Niu · 2 shared papers, 2020–2022 · strength 0.26
  9. Wenbo Zhu · 1 shared paper, 2023 · strength 0.18
  10. Chongbiao Huang · 1 shared paper, 2023 · strength 0.18
  11. Song Gao · 1 shared paper, 2023 · strength 0.18
  12. Xiaofan Guo · 1 shared paper, 2023 · strength 0.18
  13. Jihui Hao · 1 shared paper, 2023 · strength 0.18
  14. Yunyun Xu · 1 shared paper, 2023 · strength 0.17
  15. Tao Xia · 1 shared paper, 2023 · strength 0.17
  16. Yu-Li Jiang · 1 shared paper, 2019 · strength 0.16
  17. Tao Xia · 1 shared paper, 2022 · strength 0.15
  18. Yunyun Xu · 1 shared paper, 2022 · strength 0.15
  19. Ke Chen · 1 shared paper, 2020 · strength 0.11
  20. Zheling Chen · 1 shared paper, 2020 · strength 0.11
  21. Xuefeng Xu · 1 shared paper, 2019 · strength 0.09
  22. Wentao Zhou · 1 shared paper, 2019 · strength 0.09
  23. Dansong Wang · 1 shared paper, 2019 · strength 0.09
  24. Dayong Jin · 1 shared paper, 2019 · strength 0.09
  25. Tiantao Kuang · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.